Consolidated Statements of Cash Flows (unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 23, 2013	Mar. 24, 2012
Operating activities:
Net earnings	$ 2,060	$ 5,454
Adjustments to reconcile net earnings to net cash used in operating activities:
Depreciation and amortization	8,800	8,204
Amortization of deferred financing costs	313	290
Non-cash convertible debt interest	1,363	1,390
Rebateable loans	1,034	1,155
Provision for (recovery of) bad debts	18	(279)
Deferred income tax expense (benefit)	(26,783)	277
Loss (gain) on sale of property, plant and equipment	80	(476)
LIFO charge (credit)	(187)	182
Asset impairments		62
Share-based compensation expense	499	1,094
Deferred compensation	331	353
Other	(45)	(45)
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts and notes receivable	(19,336)	(2,556)
Inventories	1,831	(13,946)
Prepaid expenses	(3,893)	(1,721)
Accounts payable	(9,953)	(9,768)
Accrued expenses	3,689	(11,167)
Income taxes payable	27,488	2,699
Other assets and liabilities	285	(169)
Net cash used in operating activities	(12,406)	(18,967)
Investing activities:
Proceeds from sale of assets	313	635
Additions to property, plant and equipment	(2,779)	(4,063)
Loans to customers	(10,608)	(1,560)
Payments from customers on loans	1,205	251
Corporate-owned life insurance, net	(391)	(178)
Other		(151)
Net cash used in investing activities	(12,260)	(5,066)
Financing activities:
Proceeds from revolving debt	173,873	18,600
Dividends paid	(2,209)	(2,198)
Payments of long-term debt	(150,567)	(765)
Payments of capitalized lease obligations	(490)	(571)
Increase in outstanding checks	3,981	9,396
Payments of deferred financing costs	(6)	(41)
Tax benefit from share-based compensation		66
Other	(11)	(527)
Net cash provided by financing activities	24,571	23,960
Net decrease in cash	(95)	(73)
Cash at beginning of year	1,291	773
Cash at end of period	$ 1,196	$ 700